Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients

Strong recommendations were made to administer systemic antifungal prophylaxis to children and adolescents receiving treatment of AML, to those undergoing allogeneic HSCT pre-engraftment, and to those receiving systemic immunosuppression for graft-versus-host disease treatment.


Journal of Clinical Oncology